Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
13%
Ph phase_4
1
13%
Ph phase_3
1
13%
Ph not_applicable
3
38%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Other(2)

Detailed Status

Completed4
unknown2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A3 (50.0%)

Trials by Status

recruiting113%
completed450%
not_yet_recruiting113%
unknown225%

Recent Activity

1 active trials
Showing 5 of 8
recruitingnot_applicable

Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding

NCT07195305
not_yet_recruitingnot_applicable

Efficacy of Uterine Artery Embolization (UAE) in Management of Symptomatic Uterine Adenomyosis

NCT06652945
unknownnot_applicable

Intrauterine Device Versus Uterine Artery Embolization for Adenomyosis

NCT06043583
completedphase_4

UA Versus UAE in Treatment of Fibroids

NCT04832906
unknownphase_2

Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment

NCT02942537
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07195305Not Applicable

Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding

Recruiting
NCT06652945Not Applicable

Efficacy of Uterine Artery Embolization (UAE) in Management of Symptomatic Uterine Adenomyosis

Not Yet Recruiting
NCT06043583Not Applicable

Intrauterine Device Versus Uterine Artery Embolization for Adenomyosis

Unknown
NCT04832906Phase 4

UA Versus UAE in Treatment of Fibroids

Completed
NCT02942537Phase 2

Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment

Unknown
NCT02819609

Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids

Completed
NCT00354471

Uterine Artery Embolization for Symptomatic Fibroids

Completed
NCT00100191Phase 3

Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids

Completed

All 8 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
8